Djunadi TA, Oh Y, Lee J, Yu J, et al. Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy. Clin Lung Cancer 2024 Mar 16:S1525-7304(24)00036.
PMID: 38644088